معرفی
Sarah Tansley is a Senior Lecturer (Clinical) in the Department of Life Sciences at the University of Bath, specializing in autoimmune connective tissue diseases, particularly myositis. She leads a research group focused on autoantibody discovery and diagnostic testing, providing specialist services to the NHS and other healthcare providers. Her work bridges clinical practice and research, with a dedicated myositis clinic integrating physiotherapy and patient-reported outcomes. She holds leadership roles in international groups like the International Myositis Assessment and Clinical Studies Group (IMACS) and the European Consensus Findings Study Group (EULAR autoantibody group).
Her research emphasizes novel autoantibody detection methods, testing accuracy, and clinical translation to improve patient care. Current projects include optimizing immunoprecipitation techniques, validating diagnostic assays, and investigating autoantibody subtypes in myositis. She has secured funding from UK charities and research councils, totaling 11 active or completed projects.
Key research themes include antisynthetase syndrome classification, interlaboratory testing variability, and cancer screening guidelines for inflammatory myopathies. Her work frequently addresses diagnostic challenges and treatment efficacy, with a focus on translational outcomes. Recent publications highlight autoantibody detection improvements and their clinical implications for disease subphenotyping and therapy selection.
Awards and recognitions are not explicitly listed, but her leadership roles and extensive publication record reflect her expertise. She advises on clinical trials and collaborates internationally, contributing to both basic science and clinical guidelines in autoimmune rheumatology.
